Netherlands Lung Cancer Therapeutics Market Analysis

Netherlands Lung Cancer Therapeutics Market Analysis


$ 3999

By 2030, it is anticipated that the Netherlands Lung Cancer Therapeutics Market will reach a value of $155 Mn from $77 Mn in 2022, growing at a CAGR of 8.6% during 2022-2030. The Lung Cancer Therapeutics Market in the Netherlands is dominated by a few domestic pharmaceutical companies such as Cristal Therapeutics, ISA Pharmaceuticals, and Merus. The Lung Cancer Therapeutics Market in the Netherlands is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Netherlands lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.

ID: IN10NLPH041 CATEGORY: Pharmaceuticals GEOGRAPHY: Netherlands AUTHOR: Dr. Vishwa Modhia

Buy Now

Netherlands Lung Cancer Therapeutics Analysis Summary

By 2030, it is anticipated that the Netherlands Lung Cancer Therapeutics market will reach a value of $155 Mn from $77 Mn in 2022, growing at a CAGR of 8.6% during 2022-2030.

The Netherlands is a high-income, developed constituent country located in Western Europe and with territories in the Caribbean. There are 79 hospitals (in all, 109 locations), with seven of them being university medical centres, one being a cancer centre, and the rest being large teaching hospitals. The population-based Dutch cancer registry collects information on all patients newly diagnosed with cancer in the Netherlands. The Dutch government is devoted to the programme "smoke-free initiative."

According to the latest WHO data published in 2020 Lung Cancers Deaths in the Netherlands reached 10,980 or 8.66% of total deaths. The age-adjusted Death Rate is 29.85 per 100,000 population ranking the Netherlands #13 in the world. Netherlands' government spends 11.1% of its GDP on healthcare.

Netherlands Lung Cancer Therapeutics Analysis

Market Dynamics

Market Growth Drivers

According to Dutch guidelines, all newly diagnosed lung cancer patients must be discussed in multidisciplinary tumour boards for staging and therapy recommendations. The goal is for no one to start smoking by 2040. Several strategies have been implemented to achieve this goal. A total of 2384 NSCLC resections were performed in 2019. The Netherlands has 19 radiation oncology centres, three of which are operating proton treatment facilities. However, if palliative care specialists are required, there are 14 ESMO-designed integrated cancer and palliative care centres (with this number, the Netherlands ranks fourth in Europe). The improved infrastructure and living standards in the Netherlands are a plus. These aspects could boost the Netherlands Lung Cancer Therapeutics market.

Market Restraints

Lung cancer screening is not now a standard of care in the Netherlands. As the population ages, the Dutch pension system is under strain. The frequency of robotic-assisted thoracic surgery operations is not increasing, which could be explained in part by the related financial expenditures per procedure and the lack of proof of superiority compared to VATS. Numerous hurdles lie ahead, including the growing requirement to justify reimbursement for novel therapies and diagnostic tests, the continuation of smoke-free policies, and the need to obtain legislation to begin lung cancer screening. These factors may deter new entrants into the Netherlands Lung Cancer Therapeutics market.

Competitive Landscape

Key Players

  • Merus: Merus N.V. is a Dutch biotechnology company that focuses on the development of innovative therapies for cancer. The company is currently developing several bispecific antibodies for the treatment of lung cancer
  • ISA Pharmaceuticals: ISA Pharmaceuticals B.V. is a Dutch biopharmaceutical company that specializes in the development of immunotherapies for cancer. The company is currently developing a therapeutic vaccine for the treatment of lung cancer
  • Cristal Therapeutics: Cristal Therapeutics B.V. is a Dutch biopharmaceutical company that focuses on the development of nanomedicines for the treatment of cancer. The company is currently developing a nanomedicine-based therapy for the treatment of lung cancer
  • DCprime: DCprime is a Dutch biotechnology company that specializes in the development of immunotherapies for cancer. The company is currently developing a dendritic cell-based therapy for the treatment of lung cancer

Recent Notable Updates

August 2022: In the run-up to the implementation of mass screening for lung cancer, the Netherlands is taking part in a Europe-wide lung cancer screening trial. The first of around 400,000 persons aged 60 to 79 who are or were heavy smokers will be encouraged to come in for a CT scan in the following days and weeks. According to a Dutch-Belgian study, this instrument is efficient at detecting lung cancer in its early stages.

Healthcare Policies and Reimbursement Scenarios

In the Netherlands, the regulatory authority responsible for the approval and regulation of therapeutic products, including lung cancer therapeutics, is the Medicines Evaluation Board (MEB). The Dutch national health insurance system is founded on a universal healthcare concept, which means that every resident, regardless of ability to pay, has access to healthcare services, including cancer treatments.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Lung Cancer Therapeutics Segmentation

By Type (Revenue, USD Billion):

  • Small Cell Lung Cancer
  • Non-small Cell Lung Cancer
  • Lung Carcinoid Tumor

By Therapy (Revenue, USD Billion):

  • Radiation Therapy
  • Targeted Therapy
  • Immunotherapy
  • Chemotherapy
  • Others

By Type of Molecule (Revenue, USD Billion):

  • Small Molecules
  • Biologics

By Drug Class (Revenue, USD Billion):

  • Alkylating Agents
  • Antimetabolites
  • Multikinase Inhibitors
  • Mitotic Inhibitors
  • EGFR Inhibitors
  • Others

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 04 April 2023
Updated by: Dhruv Joshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up